Market Value1,559,401,000
Total Holdings52
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
JAZZ / Jazz Pharmaceuticals plc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc. Call
DICE / DICE Therapeutics Inc
KDNY / Chinook Therapeutics Inc
KALV / KalVista Pharmaceuticals, Inc.
KROS / Keros Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
MGTA / Magenta Therapeutics Inc
AGEN / Agenus Inc.
AVRO / AVROBIO, Inc.
FATE / Fate Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
JNCE / Jounce Therapeutics Inc
KRTX / Karuna Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
VNDA / Vanda Pharmaceuticals Inc. Call
SAGE / Sage Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Put
GHRS / GH Research PLC
VNDA / Vanda Pharmaceuticals Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
ONCR / Oncorus, Inc.
RXDX / Prometheus Biosciences Inc
NKTX / Nkarta, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
ATRA / Atara Biotherapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
RFL / Rafael Holdings, Inc.
ISEE / IVERIC bio Inc
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
SAGE / Sage Therapeutics, Inc. Call
PTGX / Protagonist Therapeutics, Inc. Put
CRNX / Crinetics Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc.
SRRA / Sierra Oncology Inc
LIFE / aTyr Pharma, Inc.
TNYA / Tenaya Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
GRTS / Gritstone bio, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
BEAM / Beam Therapeutics Inc.
GBT / Global Blood Therapeutics Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
TCDA / Tricida Inc
PASG / Passage Bio, Inc.
KURA / Kura Oncology, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
VIGL / Vigil Neuroscience, Inc.
ASMB / Assembly Biosciences, Inc.
FMTX / Forma Therapeutics Holdings Inc
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NVCR / NovoCure Limited
VRDN / Viridian Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
ESPR / Esperion Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
NKTR / Nektar Therapeutics Call
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
RPTX / Repare Therapeutics Inc.
NKTR / Nektar Therapeutics Put